In this live panel discussion, speakers navigate integrated ecosystems and the future of QARA. An executive summary is available.
On July 23, 2024, regulatory compliance professionals from large and small medical device manufacturers, drug sponsors, law firms and Big Tech gathered in Boston to discuss AI’s influence on quality assurance and regulatory affairs (QARA) at a private event hosted by IQVIA Technologies.
The first panel discussion of the day was The Benefits of a Connected Quality & Regulatory Ecosystem with guests:
- Sean McCarthy, VP of Regulatory Affairs, YourBio Health
- Deepika A. Lakhani, PhD, Senior Vice President, Chief Regulatory & Quality Officer, Lucid Diagnostics
- Sujat Sukthankar, Founder & CEO, RPD Advisors
- Krystin Meidell, Director, Global Regulatory Strategy, Combination Products, AbbVie
- Scott Kaplan, Deputy General Counsel, Baxter International Inc.
- Lori Ellis, Head of Insights, BioSpace (Moderator)
Download complete Executive Summary:
View a recap of our full event:
